Skip to content

ReActiv8 for Chronic Low Back Pain (PMCF)

Investigation of the ReActiv8 Implantable Stimulation System for Chronic Low Back Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01985230
Acronym
ReActiv8-A
Enrollment
96
Registered
2013-11-15
Start date
2014-02-28
Completion date
2024-03-31
Last updated
2024-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Low Back Pain

Brief summary

The purpose of this Clinical Study is to investigate the effect of electrical stimulation for chronic low back pain.

Interventions

DEVICEReActiv8 Implantable Stimulation System implanted and activated.

Sponsors

Mainstay Medical
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Age ≥ 18 years, ≤65 years 2. Chronic Low Back Pain with a first occurrence \>90 days prior to enrolment, and the last relatively pain-free time \>90 days prior to enrolment. 3. Continuing low back pain despite \>90 days of medical management 4. Oswestry Disability Index score ≥25% and ≤60% at the time of enrolment 5. Able to understand and sign the Informed Consent form. 6. Ability to comply with the instructions for use and to operate the ReActiv8, and to comply with this Clinical Investigation Plan. 7. Suitable for ReActiv8 surgery as determined by the implanting physician prior to inclusion. 8. Prior week average Low Back Pain NRS of ≥6.0 and ≤9.0 on a 11 point NRS scale (0-10) at the Baseline Visit

Exclusion criteria

1. BMI \> 35 2. Back Pain characteristics: 1. Any surgical correction procedure for scoliosis at any time, or a current clinical diagnosis of scoliosis. 2. Lumbar spine stenosis, as defined by an anterior-posterior diameter of the spinal canal of \<10mm in subjects with lower extremity pain 3. Neurological deficit possibly associated with the back pain (e.g. foot drop). 4. Back pain due to pelvic or visceral reasons (e.g.: endometriosis or fibroids) or infection (e.g.: post herpetic neuralgia). 5. Back pain due to inflammation or damage to the spinal cord or adjacent structures (e.g. arachnoiditis or syringomyelia) 3. Any current indication for back surgery according to local institutional guidelines, or has indication for back surgery but cannot undergo surgery for other reasons. 4. Leg pain described as being worse than back pain, or radiculopathy (neuropathic pain) below the knee. 5. Source of pain is the sacroiliac joint as determined by the Investigator. 6. Drug use 7. Surgical and other procedures exclusions 8. Any prior diagnosis of lumbar vertebral compression fracture, lumbar pars fracture, or lumbar annular tear with disc protrusion 9. Planned surgery. 10. Co-morbid chronic pain conditions 11. Other clinical conditions 12. Psycho-social exclusions 13. Protocol Compliance Exclusions 14. General exclusions

Design outcomes

Primary

MeasureTime frame
11 Point Numerical Rating Scale (NRS) for Low Back Pain90 days
Number of subjects with Adverse Events90 days, 12 months

Secondary

MeasureTime frame
Oswestry Disability Index90 days

Other

MeasureTime frame
Subject Global Impression of Change90 days

Countries

Australia, Belgium, United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026